These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6368951)

  • 1. Cardiac function in experimental uremia.
    Kreusser W; Mann J; Rambausek M; Klooker P; Mehls O; Ritz E
    Kidney Int Suppl; 1983 Nov; 15():S83-8. PubMed ID: 6368951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of preserved baseline cardiac systolic function in rats with adrenergic inotropic downregulation.
    Osadchii O; Woodiwiss A; Alves N; Norton G
    Life Sci; 2005 Dec; 78(4):366-75. PubMed ID: 16137710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure and Starling's Law of the heart.
    ter Keurs HE
    Can J Cardiol; 1996 Oct; 12(10):1047-57. PubMed ID: 9191498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.
    Yeh YH; Wakili R; Qi XY; Chartier D; Boknik P; Kääb S; Ravens U; Coutu P; Dobrev D; Nattel S
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):93-102. PubMed ID: 19808399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial function, energy provision, and carnitine deficiency in experimental uremia.
    Reddy V; Bhandari S; Seymour AM
    J Am Soc Nephrol; 2007 Jan; 18(1):84-92. PubMed ID: 17182887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension.
    Rubino A; Burnstock G
    J Pharmacol Exp Ther; 1995 Oct; 275(1):422-8. PubMed ID: 7562580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
    De Pauw M; Vilaine JP; Heyndrickx GR
    Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological studies on alterations in myocardial beta-adrenoceptors and their intracellular signal transduction in experimental diabetic rats].
    Gando S
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1140-53. PubMed ID: 7868054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacology of ASL-7022, a novel catecholamine. I. Inotropic, chronotropic and pressor actions.
    Gorczynski RJ
    J Pharmacol Exp Ther; 1982 Oct; 223(1):7-11. PubMed ID: 7120130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic beta-adrenoceptor activation on neurotensin-induced myocardial effects in rats.
    Osadchii O; Norton G; Deftereos D; Muller D; Woodiwiss A
    Eur J Pharmacol; 2006 Dec; 553(1-3):246-53. PubMed ID: 17056037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.
    Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T
    Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G proteins, beta-adrenoreceptors and beta-adrenergic responsiveness in immature and adult rat ventricular myocardium: influence of neonatal hypo- and hyperthyroidism.
    Novotny J; Bourová L; Málková O; Svoboda P; Kolár F
    J Mol Cell Cardiol; 1999 Apr; 31(4):761-72. PubMed ID: 10329204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic and cholinergic mechanisms in digitalis inotropy.
    Cook LS; Caldwell RW; Nash CB; Doherty JE; Straub KD
    J Pharmacol Exp Ther; 1982 Dec; 223(3):761-5. PubMed ID: 7143238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-death-induced cardiac contractile dysfunction: studies of possible neurohormonal and blood-borne mediators.
    Galiñanes M; Hearse DJ
    J Mol Cell Cardiol; 1994 Apr; 26(4):481-98. PubMed ID: 7915333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats.
    Osadchii O; Norton G; Woodiwiss A
    Eur J Pharmacol; 2005 May; 514(2-3):201-8. PubMed ID: 15910807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.